Title: |
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer |
Source: |
Proceedings of the National Academy of Sciences of the United States of America
[0027-8424]
Pépin,
David
yr:2015
|
|
|
|